☆ 4.6 Letter

Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States

CIRCULATION-HEART FAILURE (2023)

Re-emergence of heart failure with a normal ejection fraction?

Toru Kondo et al.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction

Muthiah Vaduganathan et al.

CIRCULATION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Paul A. Heidenreich et al.

Summary: This article provides an overview of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, including its aim, methods, and structure.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

Karen A. Hicks et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction 5-Year Outcomes

Kevin S. Shah et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

添加到收藏夹

Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States

相关参考文献

Re-emergence of heart failure with a normal ejection fraction?

Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction 5-Year Outcomes

导出引文

分享论文